Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37


Environmental Hotspots for Azole Resistance Selection of Aspergillus fumigatus, the Netherlands.

Schoustra SE, Debets AJM, Rijs AJMM, Zhang J, Snelders E, Leendertse PC, Melchers WJG, Rietveld AG, Zwaan BJ, Verweij PE.

Emerg Infect Dis. 2019 Jul;25(7):1347-1353. doi: 10.3201/eid2507.181625.


Ochroconis globalis infecting Atlantic salmon (Salmo salar), with a review of Ochroconis species in cold-blooded animals.

Samerpitak K, Alfjorden A, Seyedmousavi S, Rijs AJMM, Gerrits van den Ende AHG, de Hoog GS.

J Fish Dis. 2019 Jun;42(6):947-957. doi: 10.1111/jfd.12999. Epub 2019 Apr 12.


Single-Center Evaluation of an Agar-Based Screening for Azole Resistance in Aspergillus fumigatus by Using VIPcheck.

Buil JB, van der Lee HAL, Rijs AJMM, Zoll J, Hovestadt JAMF, Melchers WJG, Verweij PE.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01250-17. doi: 10.1128/AAC.01250-17. Print 2017 Dec.


In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.

Buil JB, Rijs AJMM, Meis JF, Birch M, Law D, Melchers WJG, Verweij PE.

J Antimicrob Chemother. 2017 Sep 1;72(9):2548-2552. doi: 10.1093/jac/dkx177.


Discrimination of Aspergillosis, Mucormycosis, Fusariosis, and Scedosporiosis in Formalin-Fixed Paraffin-Embedded Tissue Specimens by Use of Multiple Real-Time Quantitative PCR Assays.

Salehi E, Hedayati MT, Zoll J, Rafati H, Ghasemi M, Doroudinia A, Abastabar M, Tolooe A, Snelders E, van der Lee HA, Rijs AJ, Verweij PE, Seyedmousavi S, Melchers WJ.

J Clin Microbiol. 2016 Nov;54(11):2798-2803. Epub 2016 Sep 7.


Decreased Cell Wall Galactosaminogalactan in Aspergillus nidulans Mediates Dysregulated Inflammation in the Chronic Granulomatous Disease Host.

Henriet SS, van de Sande WW, Lee MJ, Simonetti E, Momany M, Verweij PE, Rijs AJ, Ferwerda G, Sheppard DC, de Jonge MI, Warris A.

J Interferon Cytokine Res. 2016 Aug;36(8):488-98. doi: 10.1089/jir.2015.0095. Epub 2016 May 4.


Combination of Amphotericin B and Flucytosine against Neurotropic Species of Melanized Fungi Causing Primary Cerebral Phaeohyphomycosis.

Deng S, Pan W, Liao W, de Hoog GS, Gerrits van den Ende AH, Vitale RG, Rafati H, Ilkit M, Van der Lee AH, Rijs AJ, Verweij PE, Seyedmousavi S.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2346-51. doi: 10.1128/AAC.02526-15. Print 2016 Apr.


Genotype-phenotype complexity of the TR46/Y121F/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus.

Snelders E, Camps SM, Karawajczyk A, Rijs AJ, Zoll J, Verweij PE, Melchers WJ.

Fungal Genet Biol. 2015 Sep;82:129-35. doi: 10.1016/j.fgb.2015.06.001. Epub 2015 Jun 16.


Emergence of fusarioses in a university hospital in Turkey during a 20-year period.

Dalyan Cilo B, Al-Hatmi AM, Seyedmousavi S, Rijs AJ, Verweij PE, Ener B, de Hoog GS, van Diepeningen AD.

Eur J Clin Microbiol Infect Dis. 2015 Aug;34(8):1683-91. doi: 10.1007/s10096-015-2405-y. Epub 2015 May 21.


High-Level Pan-Azole-Resistant Aspergillosis.

van Ingen J, van der Lee HA, Rijs AJ, Snelders E, Melchers WJ, Verweij PE.

J Clin Microbiol. 2015 Jul;53(7):2343-5. doi: 10.1128/JCM.00502-15. Epub 2015 Apr 22.


Antifungal susceptibility patterns of opportunistic fungi in the genera Verruconis and Ochroconis.

Seyedmousavi S, Samerpitak K, Rijs AJ, Melchers WJ, Mouton JW, Verweij PE, de Hoog GS.

Antimicrob Agents Chemother. 2014 Jun;58(6):3285-92. doi: 10.1128/AAC.00002-14. Epub 2014 Mar 31.


Chloroquine modulates the fungal immune response in phagocytic cells from patients with chronic granulomatous disease.

Henriet SS, Jans J, Simonetti E, Kwon-Chung KJ, Rijs AJ, Hermans PW, Holland SM, de Jonge MI, Warris A.

J Infect Dis. 2013 Jun 15;207(12):1932-9. doi: 10.1093/infdis/jit103. Epub 2013 Mar 12.


Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks.

Olthof ED, Rentenaar RJ, Rijs AJ, Wanten GJ.

Clin Nutr. 2013 Aug;32(4):538-42. doi: 10.1016/j.clnu.2012.11.014. Epub 2012 Dec 5.


Discovery of a HapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing.

Camps SM, Dutilh BE, Arendrup MC, Rijs AJ, Snelders E, Huynen MA, Verweij PE, Melchers WJ.

PLoS One. 2012;7(11):e50034. doi: 10.1371/journal.pone.0050034. Epub 2012 Nov 30.


In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.

Seyedmousavi S, Meletiadis J, Melchers WJ, Rijs AJ, Mouton JW, Verweij PE.

Antimicrob Agents Chemother. 2013 Feb;57(2):796-803. doi: 10.1128/AAC.00980-12. Epub 2012 Nov 26.


Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.

Seyedmousavi S, Brüggemann RJ, Melchers WJ, Rijs AJ, Verweij PE, Mouton JW.

J Antimicrob Chemother. 2013 Feb;68(2):385-93. doi: 10.1093/jac/dks402. Epub 2012 Nov 5.


Molecular epidemiology of Aspergillus fumigatus isolates harboring the TR34/L98H azole resistance mechanism.

Camps SM, Rijs AJ, Klaassen CH, Meis JF, O'Gorman CM, Dyer PS, Melchers WJ, Verweij PE.

J Clin Microbiol. 2012 Aug;50(8):2674-80. doi: 10.1128/JCM.00335-12. Epub 2012 Jun 6.


Identification of Paecilomyces variotii in clinical samples and settings.

Houbraken J, Verweij PE, Rijs AJ, Borman AM, Samson RA.

J Clin Microbiol. 2010 Aug;48(8):2754-61. doi: 10.1128/JCM.00764-10. Epub 2010 Jun 2.


Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles.

Snelders E, Huis In 't Veld RA, Rijs AJ, Kema GH, Melchers WJ, Verweij PE.

Appl Environ Microbiol. 2009 Jun;75(12):4053-7. doi: 10.1128/AEM.00231-09. Epub 2009 Apr 17.


Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.

Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, Mellado E, Donders AR, Melchers WJ, Verweij PE.

PLoS Med. 2008 Nov 11;5(11):e219. doi: 10.1371/journal.pmed.0050219.


Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis.

Hamza OJ, Matee MI, Moshi MJ, Simon EN, Mugusi F, Mikx FH, Helderman WH, Rijs AJ, van der Ven AJ, Verweij PE.

BMC Microbiol. 2008 Aug 12;8:135. doi: 10.1186/1471-2180-8-135.


Emericella quadrilineata as cause of invasive aspergillosis.

Verweij PE, Varga J, Houbraken J, Rijs AJ, Verduynlunel FM, Blijlevens NM, Shea YR, Holland SM, Warris A, Melchers WJ, Samson RA.

Emerg Infect Dis. 2008 Apr;14(4):566-72. doi: 10.3201/eid1404.071157. Review.


A colorimetric and spectrophotometric method for in vitro susceptibility testing of Aspergillus species against caspofungin.

Te Dorsthorst DT, Zwaaftink RB, Rijs AJ, Meletiadis J, Verweij PE.

Med Mycol. 2007 Jun;45(4):351-5.


Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis.

Klont RR, Mennink-Kersten MA, Ruegebrink D, Rijs AJ, Blijlevens NM, Donnelly JP, Verweij PE.

Clin Infect Dis. 2006 Aug 1;43(3):e23-5. Epub 2006 Jun 19.


Alternaria infectoria phaeohyphomycosis in a renal transplant patient.

Nulens E, De Laere E, Vandevelde H, Hilbrands LB, Rijs AJ, Melchers WJ, Verweij PE.

Med Mycol. 2006 Jun;44(4):379-82.


Legionella pneumophila in commercial bottled mineral water.

Klont RR, Rijs AJ, Warris A, Sturm PD, Melchers WJ, Verweij PE.

FEMS Immunol Med Microbiol. 2006 Jun;47(1):42-4.


Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.

Klont RR, Eggink CA, Rijs AJ, Wesseling P, Verweij PE.

Clin Infect Dis. 2005 Jun 15;40(12):e110-2. Epub 2005 May 12.


Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole.

Nulens E, Eggink C, Rijs AJ, Wesseling P, Verweij PE.

J Clin Microbiol. 2003 May;41(5):2261-4.


In vitro activity of amphotericin B and itraconazole in combination with flucytosine, sulfadiazine and quinolones against Exophiala spinifera.

Vitale RG, Afeltra J, de Hoog GS, Rijs AJ, Verweij PE.

J Antimicrob Chemother. 2003 May;51(5):1297-300. Epub 2003 Apr 14.


Invasive infections due to Apophysomyces elegans.

Dannaoui E, Rijs AJ, Verweij PE.

Mayo Clin Proc. 2003 Feb;78(2):252-3. No abstract available.


Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998.

Verweij PE, Te Dorsthorst DT, Rijs AJ, De Vries-Hospers HG, Meis JF.

J Clin Microbiol. 2002 Jul;40(7):2648-50.


Comparative study of seven commercial yeast identification systems.

Verweij PE, Breuker IM, Rijs AJ, Meis JF.

J Clin Pathol. 1999 Apr;52(4):271-3.


In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.

Verweij PE, Mensink M, Rijs AJ, Donnelly JP, Meis JF, Denning DW.

J Antimicrob Chemother. 1998 Sep;42(3):389-92.


Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan.

Swanink CM, Meis JF, Rijs AJ, Donnelly JP, Verweij PE.

J Clin Microbiol. 1997 Jan;35(1):257-60.


Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients.

Verweij PE, Stynen D, Rijs AJ, de Pauw BE, Hoogkamp-Korstanje JA, Meis JF.

J Clin Microbiol. 1995 Jul;33(7):1912-4.


Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis.

Verweij PE, Rijs AJ, De Pauw BE, Horrevorts AM, Hoogkamp-Korstanje JA, Meis JF.

J Clin Pathol. 1995 May;48(5):474-6.

Supplemental Content

Support Center